Eleven Biotherapeutics Reports Fiscal First Quarter 2014 Financial Results

Published: May 15, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Eleven Biotherapeutics, Inc. (Nasdaq: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today reported financial results and operational highlights for the quarter ended March 31, 2014.

Help employers find you! Check out all the jobs and post your resume.

Back to news